ERAPs (ERAP1 and ERAP2) are emerging therapeutic targets associated with multiple autoimmune diseases. Genomics will assemble the largest available genetic resource to evaluate how ERAP variants influence an individual’s risk of developing multiple autoimmune diseases.  Insights will be used to strengthen Greywolf Therapeutics’ autoimmune disease pipeline. Oxford, England -- Genomics, a science-led techbio company using large-scale [...]

New PTC Harmony Thermal Cycler Line Expands Access to Reliable, High-Performance PCR Across Academic and Biopharma Laboratories HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of the PTC Harmony Thermal Cycler line, designed to offer broader access to [...]

BRANFORD, Conn. --  Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that the company has successfully demonstrated sequencing on integrated Proteus™ instruments. This milestone was achieved using a developmental sequencing kit, the KinetIQ™ Array, and fully integrated Proteus instruments. The developmental sequencing kit [...]

Expansion of Plainville, Mass., facility offers bioprocessing expertise, advanced technologies and customized support WALTHAM, Mass. -- Thermo Fisher Scientific Inc., the world leader in serving science, today announced the opening of its flagship U.S. Bioprocess Design Center (BDC) at the company’s Plainville, Mass., site, expanding the facility to support customers in developing and scaling biologics. [...]

iPSC-derived endothelial cells support vascular biology, drug discovery and toxicity studies BEACHWOOD, Ohio -- Trailhead Biosystems, Inc. (TrailBio.com), a biotechnology company advancing human cell innovation, announces the commercial launch of TrailBio® Endothelial Cells, a functionally validated iPSC-derived model of the human vascular endothelium. Trailhead_Biosystems_Inc_Product_Data_Sheet_Image TrailBio® Endothelial Cells are differentiated from human induced pluripotent stem cells (iPSCs) [...]

Authorization expands academic and industry researcher access for LNP delivery optimization, mRNA vaccine development and gene therapy research MADISON, Wis. -- A new agreement between Promega Corporation and the RNA & Formulation Core at the University of British Columbia will enable the facility to manufacture and distribute mRNA constructs incorporating the sequence encoding NanoLuc® luciferase. This will facilitate researchers [...]

Transforming complex bioimaging data to workflows offering actionable insights for decision-making to speed up drug discovery Integrated solutions: Seamless integration of EDGE-developed quantitative assays with scalable hardware and AI-driven analytics from ZEISS to redefine bioimaging in biopharma Strategic focus: Enabling automation and enhancing decision-making through quantitative imaging, establishing an AI-native data foundation accelerating GenAI adoption Customer impact: Standardized [...]

SAN DIEGO -- Singular Genomics Systems, Inc. today announced the appointment of John Stark as Chief Executive Officer. This leadership transition comes as Singular builds on the launch of its market-leading spatial platform and enters its next phase, focused on expanding adoption, deepening strategic partnerships, and increasing the impact of multimodal spatial data across translational research, drug development, and future [...]

Supports a wide range of spectral data, including XPS, FT-IR, and NMR. From automatic determination of peak count and peak shape to background and noise estimation, AutoStatSpectra enables analysis with less dependence on individual analyst experience. TAIPEI and SINGAPORE -- a.s.ist Inc. ("a.s.ist") leverages research expertise cultivated at The University of Tokyo to drive digital transformation [...]

Amsbio has expanded its range of iPSC Differentiation Kits that provide fast and flexible generation of specific cell types without sacrificing cell purity. New to market - Quick-Glia™ product line consist of human induced pluripotent stem cell derived glial cells designed for rapid, reliable, and reproducible research in neurobiology, drug discovery, and neurodegeneration. Offering a reproducible, and scalable solution, these [...]